Papillomavirus binding factor (PBF) was first identified as a
transcription factor regulating the promoter activity of human papillomavirus. We previously demonstrated that PBF is an
osteosarcoma-associated antigen and 92% of
osteosarcoma tissues express PBF in the nucleus. Moreover, PBF-positive
osteosarcoma has a significantly poorer prognosis than that with negative expression of PBF. In the present study, we assessed the
biological role of PBF in cell survival. Overexpression of PBF induced cell death-mediated
lactate dehydrase (LDH) release from 293EBNA cells. Cleaved
poly(ADP-ribose) polymerase and active
caspase-3 were also detected. However, PBF-induced apoptosis did not affect
caspase-9 activity. Next, to identify the apoptosis regulator of PBF, we screened a cDNA library constructed from
mRNA of the
osteosarcoma cell line OS2000 using a yeast two-hybrid system and isolated Scythe/BAT3. Scythe/BAT3
mRNA was detected in 56% of
osteosarcoma tissues and ubiquitously in various normal tissues. Although Scythe/BAT3 was localized to the cytoplasm in normal tissue, it was localized to the nucleus in
osteosarcoma tissue. PBF and Scythe/BAT3 also colocalized to the cytoplasm in 293T cells and the nucleus in OS2000. Furthermore, overexpression of Scythe/BAT3 suppressed cell death events that resulted from overexpression of PBF in OS2000, but not in 293EBNA cells. Thus, our results support the ideas that: (i) PBF could induce apoptotic cell death via a caspase-9-independent pathway; (ii) the apoptosis regulator Scythe/BAT3 is a PBF-associated molecule acting as a nucleus-cytoplasm shuttling
protein; and (iii) colocalization of PBF and Scythe/BAT3 in the nucleus might be an important factor for survival of
osteosarcoma cells.